BILL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BILL Holdings is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has some fundamental support from analyst targets, hedge fund buying, and a recent revenue growth update, but the current technical setup is still weak and the proprietary trading signals do not show a buy. I would not buy here; I would wait for a clearer trend improvement.
The price is 34.84, essentially flat versus the previous close, but the chart setup remains bearish. MACD histogram is -0.526 and worsening, which confirms downside momentum. Moving averages are aligned bearishly with SMA_200 > SMA_20 > SMA_5, showing the stock is still below a sustained uptrend. RSI_6 at 24.428 is very weak and near oversold territory, but not enough by itself to confirm a reversal. Key support is around 34.922, and the stock is trading right at that level; if it fails, the next support is 33.218. Resistance sits at 37.68, then 40.438. The short-term stock pattern data also implies a downside bias over the next week and month.
["Truist still rates the stock Buy and recently kept a $45 target.", "Goldman Sachs raised its target to $50 and kept a Buy rating.", "Oppenheimer raised its target to $55 and highlighted $110M of annualized savings from workforce optimization.", "Hedge funds are buying, with buying amount up 111.02% over the last quarter.", "Latest quarter revenue reportedly increased 13% year over year.", "Management changes and AI-native restructuring could improve execution over time."]
["The stock is trading with bearish moving averages and negative MACD momentum.", "RSI is weak, reflecting ongoing selling pressure rather than a confirmed reversal.", "Some analysts remain cautious, including Neutral/Equal Weight/Market Perform views.", "Light Street Capital sold 253,000 shares, signaling reduced confidence.", "The stock trend model suggests downside probability over the next day, week, and month.", "No AI Stock Picker or SwingMax buy signal is present today.", "No recent congress trading data is available to support a sentiment boost."]
The latest quarter appears to have shown solid top-line progress, with revenue up 13% year over year. That is a constructive growth trend for a company like BILL, especially for a long-term thesis. However, the provided financial snapshot is incomplete, so profitability, operating margin, and cash flow trend cannot be fully assessed from the data given. The recent analyst notes suggest improved FY2027 earnings expectations partly from restructuring and buybacks, which is positive for long-term earnings leverage.
Analyst sentiment is mixed but improved overall. Several firms raised price targets recently, including Goldman Sachs to $50, Keefe Bruyette to $49, Morgan Stanley to $55, Baird to $54, and Oppenheimer to $55. Truist lowered its target slightly to $45 but kept Buy. The range of ratings shows a split Wall Street view: the bulls see upside from revenue growth, efficiency gains, and buybacks, while the neutral camp still wants clearer execution. Net-net, Wall Street is cautiously constructive but not universally bullish.
